TNF and ankylosing spondylitis: Similarly, a previous study [18] from our group of 107 Korean patients with either rheumatoid arthritis or ankylosing spondylitis who received TNF-α antagonist therapy and were followed up for 13–33.5 months found that no patients developed active TB.